1.5 Vascular Access Planning, Skin Preparation & Sterile Draping

1.5 Vascular Access Planning, Skin Preparation & Sterile Draping

Vascular access is the physical gateway to all invasive cardiac electrophysiology procedures. Gaining safe, rapid, and uncomplicated entry into the venous and arterial circulations requires mastery of regional anatomy, understanding of fluoroscopic and ultrasonographic guidance, meticulous skin antisepsis, and rigorous weight-based local anesthetic dosing. Vascular complications—including retroperitoneal hemorrhage, pseudoaneurysms, arteriovenous fistulas, and surgical site infections—remain among the most common sources of periprocedural morbidity in the EP laboratory.

---

Vascular Access Anatomy & The Femoral Triangle

The majority of diagnostic and therapeutic electrophysiology procedures utilize the femoral venous system to introduce multi-electrode mapping and ablation catheters into the right heart, coronary sinus, and transseptally into the left atrium.

Boundaries of the Femoral Triangle (Scarpa's Triangle)

• Superior Boundary: The inguinal ligament, extending obliquely from the anterior superior iliac spine (ASIS) to the pubic tubercle.
• Lateral Boundary: Medial border of the sartorius muscle.
• Medial Boundary: Medial border of the adductor longus muscle.
• Floor: Formed laterally by the iliopsoas muscle and medially by the pectineus muscle.
• Roof: Fascia lata and the cribriform fascia.

Neurovascular Relationships (The NAVEL Mnemonic)

Traversing the femoral triangle beneath the inguinal ligament, the anatomical structures lie in a strict lateral-to-medial orientation, memorized by the classic acronym NAVEL:

• N — Nerve (Femoral Nerve): Lies most lateral, outside the femoral vascular sheath, positioned on the surface of the iliopsoas muscle. Accidental needle contact produces acute electric-like shooting pain radiating down the anterior thigh into the knee.
• A — Artery (Common Femoral Artery [CFA]): Enclosed in the lateral compartment of the fibrous femoral sheath. Lies directly over the center-to-lateral aspect of the bony femoral head.
• V — Vein (Common Femoral Vein [CFV]): Enclosed in the intermediate compartment of the femoral sheath, positioned immediately medial to the common femoral artery. The CFV is the primary target for diagnostic and ablation catheters passing upward into the inferior vena cava (IVC).
• E — Empty Space (Femoral Canal): The medial compartment of the femoral sheath, containing loose areolar tissue and fat. This space allows the common femoral vein to expand during times of increased venous return or elevated right heart pressures.
• L — Lymphatics: Deep inguinal lymph nodes (including the Cloquet/Rosenmüller node) and lymphatic channels occupying the medial aspect of the canal.

---

Skeletal & Fluoroscopic Landmarking: High vs. Low Puncture Dynamics

Precise puncture localization along the femoral neurovascular bundle dictates whether hemostasis can be achieved safely or whether catastrophic vascular complications will occur.

The Fallacy of the Cutaneous Inguinal Crease

A dangerous clinical pitfall is relying on the skin crease of the groin to guide vascular access. In normal-weight individuals, the cutaneous crease typically lies 2 to 3 cm inferior to the true inguinal ligament. In elderly, obese, or morbidly obese patients with an overhanging abdominal pannus, the cutaneous fold is displaced 5 to 7 cm distal to the inguinal ligament. Puncturing at the skin crease in an obese patient almost guarantees entry below the femoral bifurcation.

Fluoroscopic Guidance: The Femoral Head Target Zone

Before needle insertion, the fluoroscopy C-arm is placed in an Anterior-Posterior (AP) orientation over the ipsilateral hip to visualize the bony landmarks:

• Target Puncture Zone: The needle should enter the common femoral vein directly over the medial third of the bony femoral head, between the equator (horizontal centerline) and the inferior margin of the femoral head.
• Superior Limit: The inferior border of the inferior epigastric artery, which marks the emergence of the external iliac vessels beneath the inguinal ligament (crossing near the superior margin of the femoral head).
• Inferior Limit: The bifurcation of the common femoral vein and artery, which typically occurs near the lower margin of the femoral head or upper femoral neck.

Complications of High Vascular Puncture

• Retroperitoneal Hemorrhage: Puncturing superior to the inguinal ligament enters the external iliac vein or external iliac artery within the retroperitoneal space.
• Pathophysiology: The retroperitoneal space is an uncontained, highly compliant anatomical cavity. Crucially, the external iliac vessels reside inside the pelvic brim, where manual compression against bone is physically impossible. Even if manual pressure is held firmly on the skin of the groin, blood from a high puncture site pours freely into the retroperitoneum.
• Clinical Presentation: The presentation is notoriously occult and delayed. The patient frequently complains of vague lower back, flank, or lower quadrant abdominal pain. As blood volume (1 to 2+ liters) pools in the pelvis, the patient develops progressive, unexplained sinus tachycardia and hypotension refractory to fluid boluses, followed by a precipitous drop in hemoglobin/hematocrit. Retroperitoneal hematoma carries a mortality rate of 10% to 15% if unrecognized.

Complications of Low Vascular Puncture

• Puncturing inferior to the femoral head or below the bifurcation enters the superficial femoral vein/artery or the profunda femoris (deep femoral) vessels.
• Pathophysiology: These branch vessels have smaller calibers, thinner muscular walls, and lack the firm posterior bony support of the femoral head, making effective manual compression difficult.
• Clinical Complications:
  • Femoral Pseudoaneurysm (PSA): An arterial puncture that fails to seal completely, allowing blood to jet into the surrounding perivascular tissue, creating a pulsatile, blood-filled fibrous sac that remains in direct communication with the arterial lumen. Characterized by a pulsatile groin mass, audible systolic bruit, and risk of rupture or femoral nerve compression.
  • Arteriovenous (AV) Fistula: Occurs when a low puncture needle traverses both the superficial femoral artery and adjacent branch veins simultaneously (a through-and-through puncture). This creates a direct abnormal connection between the high-pressure arterial and low-pressure venous systems, manifested by a continuous "machinery-like" thrill/bruit, venous engorgement, and high-output heart failure.
  • Extensive Hematoma & Venous Thrombosis: Low punctures predisposing to vessel dissection, deep vein thrombosis, and large painful groin hematomas.

---

Ultrasound-Guided Vascular Access & Micropuncture Technique

Real-time ultrasound guidance has replaced blind landmark palpation as the standard of care in modern electrophysiology suites, dramatically reducing access attempts, accidental arterial punctures, and hemorrhagic complications.

Ultrasound Imaging Principles

• Uses a high-frequency linear array transducer (7 to 12 MHz) enclosed in a sterile sheath with acoustic coupling gel.
• Transverse (Short-Axis) View: The probe is held perpendicular to the long axis of the thigh.
  • Vessel Differentiation: The common femoral artery appears round, thick-walled, pulsatile, and resists moderate transducer pressure. The common femoral vein lies medial to the artery, exhibits a thinner wall, is typically larger in diameter, and collapses completely under gentle probe pressure.
  • Anatomical Variations: In 10% to 15% of patients, the common femoral artery partially or completely overlaps the common femoral vein anteriorly. Blind needle insertion in such patients results in through-and-through transfixion of the artery into the vein, directly causing an arteriovenous fistula.
• Longitudinal (Long-Axis) View: The probe is rotated 90 degrees parallel to the vessel lumen. This allows continuous visualization of the echogenic needle shaft and tip as it approaches and punctures the anterior vein wall ("tenting"), ensuring that the posterior wall is not perforated.

The 21-Gauge Micropuncture Technique

Standard vascular access kits utilize an 18-gauge Cook-style needle (outer diameter ~1.27 mm). If an 18-gauge needle accidentally enters the common femoral artery or external iliac vessel, the resulting large puncture hole can bleed catastrophically, particularly in fully anticoagulated patients.

• Micropuncture Components: Utilizes a 21-gauge thin-walled echogenic needle (outer diameter ~0.71 mm), a 0.018-inch nitinol access guidewire with a floppy radiopaque tip, and a 4-5 Fr coaxial transition dilator/sheath.
• Clinical Advantage: A 21-gauge needle produces an entry footprint that is less than one-third the cross-sectional area of an 18-gauge needle. If an accidental arterial or through-and-through venous puncture occurs with a 21-gauge needle, bleeding readily self-seals without significant hematoma or pseudoaneurysm formation.

---

Alternative Venous Access Sites

While the femoral veins are the workhorse conduits in electrophysiology, alternative access routes are frequently required for specific catheter placements or device implants.

Right Internal Jugular Vein (RIJ)

• Anatomy: Courses through the carotid sheath lateral and slightly anterior to the common carotid artery, terminating behind the sternoclavicular joint where it unites with the subclavian vein to form the brachiocephalic (innominate) vein.
• EP Indications: Provides a direct, straight-line inferior trajectory through the superior vena cava (SVC) into the right atrium, making it the ideal access site for cannulating the coronary sinus (CS) in challenging anatomies, performing right ventricular endomyocardial biopsies, or inserting temporary transvenous pacing wires.
• Guidance & Safety: Real-time ultrasound guidance is mandatory to prevent accidental common carotid artery puncture, carotid dissection, pneumothorax, or puncture of the adjacent vagus nerve. Left IJ cannulation is generally avoided due to the tortuous path of the left innominate vein and the proximity of the thoracic duct.

Subclavian and Axillary Vein Access

• Anatomy & Indications: Primary access route for transvenous pacemaker, ICD, and CRT lead implantation.
• The Axillary Vein Approach: Cannulation of the extrathoracic axillary vein over the outer border of the first or second rib under fluoroscopic or ultrasound guidance has widely replaced traditional medial "blind" subclavian puncture.
• Prevention of Subclavian Crush Syndrome: Medial subclavian puncture enters the vein within the tight costoclavicular space bounded by the clavicle, the first rib, and the subclavius muscle/costoclavicular ligament. Leads entering through this medial space are subjected to repetitive mechanical compression and shear stress during arm movement. Over months to years, this chronic friction causes subclavian crush syndrome—manifested by outer insulation degradation, conductor coil fracture, electrical open circuits, and catastrophic failure of lead function. Puncturing the axillary vein lateral to the first rib completely avoids the costoclavicular space, eliminating mechanical crush injury.

---

Skin Preparation & Surgical Draping Protocols

Surgical site infections (SSIs) following CIED implantation or invasive vascular cannulation carry profound clinical consequences, ranging from device pocket erosion and systemic bacteremia to endocarditis requiring complete system extraction.

Antiseptic Formulations: CHG versus Povidone-Iodine

• Gold Standard Formulation: 2% Chlorhexidine Gluconate (CHG) in 70% Isopropyl Alcohol (IPA).
  • Mechanism: Isopropyl alcohol acts instantly to denature microbial proteins, achieving a rapid 99.9% bacterial kill within 30 seconds. Chlorhexidine gluconate binds persistently to the negatively charged epithelial stratum corneum, providing sustained, broad-spectrum residual antibacterial activity lasting 48 to 72 hours.
  • Clinical Superiority: Randomized clinical trials have demonstrated that 2% CHG with 70% IPA reduces surgical site infections and catheter-related bloodstream infections (CRBSIs) by more than 50% compared to traditional 10% aqueous povidone-iodine.

Application Technique & The 3-Minute Dry Time Rule

1. Application Friction:
   • For dry surgical sites (e.g., prepectoral pocket): Apply using repeated, vigorous back-and-forth friction scrubs for at least 30 seconds.
   • For moist sites with high bacterial bioburden (e.g., inguinal groin folds): Apply vigorous back-and-forth friction scrub for a full 2 minutes to penetrate deep intertriginous crevices and hair follicles.
2. Mandatory Air-Drying Time (The 3-Minute Rule):
   • The solution must be permitted to completely air-dry for a MINIMUM OF 3 MINUTES before placing sterile drapes.
   • Surgical Fire Prevention: The 70% isopropyl alcohol solvent is highly volatile and flammable. If sterile drapes are placed prematurely over wet or partially evaporated prep, alcohol vapors become trapped beneath the drape canopy. When supplemental oxygen is delivered to the patient and an ignition source (electrocautery, RF ablation current, or defibrillation discharge) is activated, an explosive flash fire can ignite instantly beneath the drapes, causing catastrophic 3rd-degree burns and airway injury. Preps must never be blotted dry with towels, nor fanned.

Sterile Draping

• Wide sterile barrier drapes must cover the patient from head to toe, with bilateral transparent side fenestrations permitting continuous fluoroscopic visualization of the pelvis, chest, and diaphragm while maintaining sterile isolation.

---

Local Anesthesia Administration, Buffering & Toxicity (LAST)

Adequate local anesthesia minimizes patient distress, blunts sympathetic surges, and prevents sudden movement during critical vascular cannulation.

Pharmacology of Lidocaine Hydrochloride

• Mechanism: An amino-amide local anesthetic that reversibly blocks voltage-gated sodium channels on the internal surface of nerve cell membranes, preventing the influx of sodium necessary for action potential generation and propagation.
• Formulations: Commonly supplied as 1% (10 mg/mL) or 2% (20 mg/mL) lidocaine hydrochloride.

Sodium Bicarbonate Buffering

• Commercial lidocaine solutions are packaged at an acidic pH (5.0 to 6.5) to maintain chemical stability and retard oxidation. Subcutaneous injection of this acidic solution causes intense, painful burning and stinging.
• Buffering Protocol: Add 1 mL of 8.4% Sodium Bicarbonate (1 mEq/mL) to 9 or 10 mL of 1% lidocaine (a 1:10 ratio).
• Biophysical Mechanism: Alkalinization raises the solution pH toward the pKa of lidocaine (7.9), converting a higher fraction of the drug from its ionized (charged) form into its uncharged, lipophilic base form. The lipid-soluble base rapidly traverses the perineural fibrous sheath and neuronal lipid bilayer, accelerating onset of action to < 1 minute and virtually eliminating injection pain.

Maximum Safe Weight-Based Dosing

Exceeding maximum recommended doses or accidentally injecting local anesthetic directly into an artery or vein can precipitate fatal toxicity:

• Plain Lidocaine (without epinephrine): Maximum safe dose is 4.5 mg/kg (not to exceed a total maximum dose of 300 mg in adults).
  • Example: In a 70-kg adult, 70 kg × 4.5 mg/kg = 315 mg maximum (~31 mL of 1% lidocaine).
• Lidocaine with Epinephrine (1:100,000 or 1:200,000): Maximum safe dose is 7.0 mg/kg (not to exceed a total maximum dose of 500 mg in adults). Epinephrine induces local arteriolar vasoconstriction, slowing systemic vascular uptake and prolonging duration of anesthesia. Clinical Note: Epinephrine should be used with extreme caution or avoided in patients with severe coronary artery disease, unstable ventricular arrhythmias, or when baseline mapping of idiopathic PVCs is planned.

Local Anesthetic Systemic Toxicity (LAST)

LAST is a life-threatening medical emergency caused by toxic plasma concentrations of local anesthetics affecting the central nervous system (CNS) and cardiovascular system (CVS).

• CNS Progression: Initial symptoms reflect cortical excitation (perioral numbness, metallic taste in the mouth, auditory ringing / tinnitus, visual disturbances, slurred speech, facial twitching, tremors). This rapidly progresses to generalized tonic-clonic seizures, followed by profound CNS depression (stupor, coma, respiratory arrest).
• Cardiovascular Progression: Myocardial sodium channel blockade depresses phase 0 depolarization, slowing intraventricular conduction. Manifests as prolonged PR interval, wide QRS complexes, bundle branch block, profound sinus bradycardia, refractory hypotension, polymorphic ventricular tachycardia, and asystole.

Management of LAST: The 20% Lipid Emulsion Resuscitation Protocol

1. Immediate Actions: Cease local anesthetic injection instantly; call for emergency help and the LAST Emergency Rescue Box (containing 20% Intralipid).
2. Airway & Oxygenation: Ventilate with 100% oxygen; perform endotracheal intubation if airway reflexes or ventilation fail. Avoid hyperventilation (hypocapnia promotes intracellular local anesthetic uptake) and hypoventilation (acidosis and hypoxia markedly worsen toxicity).
3. Seizure Management: Administer small doses of intravenous benzodiazepines (midazolam 1 to 2 mg IV). Avoid propofol in hemodynamically unstable patients due to profound myocardial depression.
4. ACLS Modifications: Reduce standard epinephrine doses to < 1 mcg/kg (e.g., 10 to 100 mcg IV boluses in adults); avoid vasopressin, calcium channel blockers, and beta-blockers. Avoid lidocaine, procainamide, or other class I antiarrhythmics.
5. Intravenous 20% Lipid Emulsion (Intralipid) Resuscitation Protocol:
   • Mechanism: Acts as a "lipid sink"—creating an expanded intravascular lipid phase that pulls lipophilic local anesthetic molecules away from high-affinity cardiac and neural tissue; also provides high-energy fatty acid substrate to poisoned myocardial mitochondria.
   • Initial IV Bolus: Administer 1.5 mL/kg of 20% lipid emulsion IV over 1 minute (~100 mL in a 70-kg adult).
   • Continuous IV Infusion: Immediately follow bolus with a continuous infusion of 0.25 mL/kg/min (~18 mL/min in a 70-kg adult).
   • Refractory Instability: If hemodynamic stability is not restored, repeat the 1.5 mL/kg bolus every 3 to 5 minutes (up to a maximum of 2 additional boluses) and increase the infusion rate to 0.5 mL/kg/min.
   • Upper Limit: Continue infusion for at least 10 minutes after hemodynamic recovery; do not exceed a total cumulative dose of 10 to 12 mL/kg in the first 30 minutes.